Base line 1 2 3 4 5 6 Mean P value AH glargine 1.70 ± 1.50 0.85  ±  0.89 0.50 ± 0.59 0.38 ± 0.66 0.65 ± 1.05 0.38 ± 0.70 0.13 ± 0.33 0.65 ± 0.51        0.005 NPH 1.50  ± 1.01 2.45 ± 4.9 1.60 ± 1.29 1.55 ± 1.30 1.45 ± 1.21 1.23 ± 1.33 1.05 ± 1.21 1.54 ± 0.44 SymH glargine 1.20  ±  1.2 0.45 ± 0.63 0.31 ± 0.52 0.28 ± 0.59 0.35 ± 0.58 0.23 ± 0 .53 0.05 ± 0.31 0.41 ± 0.36     0.008 NPH 1.05 ± 0.93 0.98 ± 1.05 1.05  ± 1.1 0.85  ± 1.00 0.75 ± 0.92 0.80 ± 0 .91 0.70 ± 0.99 0.88 ± 0.14 SH glargine 0.65 ± 0 .77 0.05 ± 0.22 0.18 ± 0.38 0.20 ± 0.40 0.18 ± 0.38 0.13 ± 0.40 0.05 ± 0.22 0.20 ± 0.20     0.0001 NPH 0.70 ± 0.85 0.80 ± 0.82 0.83 ± 0.87 0.68 ± 0.85 0.58 ± 0.84 0.50 ± 0.71 0.48 ± 0.75 0.65 ± 0.13 NH glargine 0.55 ± 0.93 0.18 ± 0.54 0.10 ± 0.30 0.10 ± 0.37 0.03 ± 0.15 0.01 ± 0.01 0.03 ± 0.16 0.14 ± 0.18     0.748 NPH 0.53 ± 0.91 0.21 ± 0.56 0.18 ± 0.44 0.09 ± 0.32 0.04 ± 0.19 0.08 ± 0.34 0.09 ± 0.28 0.17 ± 0.16

Table 4: Mean episodes of hypoglycemia in the study groups at follow-up visits.